Recall: D-1424-2014
Class II - Potentially Harmful
Class IIClassification
2014-05-16Initiated
TerminatedStatus
Hospira Inc.Firm
Product
Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20
Reason
Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution
Distribution
Nationwide
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.